Nida Shah, Associate Director of TDR Lung Franchise Project and Portfolio Management within Oncology Global Medical Affairs at AstraZeneca, shared on LinkedIn:
“I’m excited to share that I’ve started a new position as Associate Director, TDR Lung Franchise Project and Portfolio Management within Oncology Global Medical Affairs at AstraZeneca.
This new role is an exciting opportunity to further develop my understanding of medical strategy, contribute to impactful portfolio initiatives, and help advance work that can make a meaningful difference for patients living with lung cancer.
I’m grateful to everyone who has supported my development and encouraged me throughout my journey. Your guidance, collaboration, and belief in me have been tremendously important, and I look forward to continuing to learn, grow, and make an impact in this next chapter.”
Read about AstraZeneca and Daiichi Sankyo’s latest clinical trial updates:
